Anti-OR8U8 monoclonal antibody

Pre-made anti-OR8U8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to OR8U8/OR8U8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2900-Ab-1/ GM-Tg-hg-IP2900-Ab-2Anti-Human OR8U8 monoclonal antibodyHuman
GM-Tg-rg-IP2900-Ab-1/ GM-Tg-rg-IP2900-Ab-2Anti-Rat OR8U8 monoclonal antibodyRat
GM-Tg-mg-IP2900-Ab-1/ GM-Tg-mg-IP2900-Ab-2Anti-Mouse OR8U8 monoclonal antibodyMouse
GM-Tg-cynog-IP2900-Ab-1/ GM-Tg-cynog-IP2900-Ab-2Anti-Cynomolgus/ Rhesus macaque OR8U8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2900-Ab-1/ GM-Tg-felg-IP2900-Ab-2Anti-Feline OR8U8 monoclonal antibodyFeline
GM-Tg-cang-IP2900-Ab-1/ GM-Tg-cang-IP2900-Ab-2Anti-Canine OR8U8 monoclonal antibodyCanine
GM-Tg-bovg-IP2900-Ab-1/ GM-Tg-bovg-IP2900-Ab-2Anti-Bovine OR8U8 monoclonal antibodyBovine
GM-Tg-equg-IP2900-Ab-1/ GM-Tg-equg-IP2900-Ab-2Anti-Equine OR8U8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2900-Ab-1/ GM-Tg-hg-IP2900-Ab-2; GM-Tg-rg-IP2900-Ab-1/ GM-Tg-rg-IP2900-Ab-2;
GM-Tg-mg-IP2900-Ab-1/ GM-Tg-mg-IP2900-Ab-2; GM-Tg-cynog-IP2900-Ab-1/ GM-Tg-cynog-IP2900-Ab-2;
GM-Tg-felg-IP2900-Ab-1/ GM-Tg-felg-IP2900-Ab-2; GM-Tg-cang-IP2900-Ab-1/ GM-Tg-cang-IP2900-Ab-2;
GM-Tg-bovg-IP2900-Ab-1/ GM-Tg-bovg-IP2900-Ab-2; GM-Tg-equg-IP2900-Ab-1/ GM-Tg-equg-IP2900-Ab-2
Products NameAnti-OR8U8 monoclonal antibody
Formatmab
Target NameOR8U8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-OR8U8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2900-Ag-1Recombinant multi-species OR8U8 protein


    Target information

    Target IDGM-IP2900
    Target NameOR8U8
    Gene ID504189
    Gene Symbol and SynonymsOR8U8
    Uniprot AccessionP0C7N1
    Uniprot Entry NameOR8U8_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000262315
    Target ClassificationN/A

    The target: OR8U8, gene name: OR8U8, also named as . Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.